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Abstract 
Trigeminal neuralgia (TN) is a form of neuropathic pain that affects the fifth cranial nerve, the most 
widely distributed nerve in the head. Although TN has been associated with a variety of 
pathological conditions, neurovascular compression on the trigeminal nerve, as it exits the brain 
stem, is the most frequent reported cause. This compression provides a progressive demyelination 
of the nerve and a subsequent aberrant neural transmission. Although several studies have clarified 
some physiopathological mechanisms underlying TN, the molecular basis remains vague. Very 
recently the substitution of methionine 136 by valine (MET126Val) in sodium channel Nav1.6 in a 
case study of typical TN has suggested a new possible mechanism for TN.  
The findings of this new mutation provide novel information that warrants further conclusive 
investigations. 
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Trigeminal neuralgia (TN) is a debilitating form of facial pain accounting for serious 
discomfort and reduction in quality of life. This disease has an annual incidence of about 4.5 per 
100,000 with a female/male ratio of 2.3 (1). In its classic form, TN is characterized by paroxysmal 
and recurrent painful attacks lasting for fractions of seconds with a distribution to one or more 
divisions of the trigeminal roots. Patients suffering from TN described an unbearable, excruciating 
discomfort, sometimes severe enough to lead to suicide. The painful attacks, generated by the 
stimulation of triggers points corresponding to the facial emergence of the trigeminal nerve, are 
often produced by normal stimuli such as light touch, shaving, teeth washing, or eating. According 
to the International Classification of Headache Disorders, the etiology of TN is divided into a 
classical form, caused by vascular compression of the trigeminal nerve root, and one symptomatic, 
caused by other factors such as tumors, vascular disorders, demyelination in multiple sclerosis (2). 
Among several pathophysiological mechanisms, several line of evidence has contributed in 
promoting the role of vascular compression in the posterior fossa as causative factor for TN. In this 
regard, in 1932 Dandy proposed the compression of the trigeminal nerve at its point of entry into 
the pons, from arterial vessels (the superior cerebellar artery), as a possible cause of TN (3). 
Subsequently, the concept of vascular compression of cranial nerves in the posterior fossa has been 
further investigated in numerous clinical and autoptic studies. Currently, we do know that patients 
with trigeminal neuralgia, hemifacial spasm, glossopharyngeal neuralgia and other cranial nerve 
dysfunction syndromes may have blood vessels closely with the respective cranial nerves and that 
separating the blood vessel from the nerve by interposing a soft implant between them 
(microvascular decompression) may be curative (4-6). Although neurovascular compression is 
considered the etiological factor most frequently observed in hyperactivity syndromes of the cranial 
nerves, the biochemical mechanisms underlying nerve dysfunction are still unclear. Among the 
many theories proposed, it has been suggested that these clinical syndromes result from a pulsatile 
compression by arteries at the root entry/exit zone of the cranial nerve, a junctional area between 
central and peripheral myelin (7).  
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Accordingly, the pain is attributed to hyperactivity or abnormal discharge arising from the gasserian 
ganglion, injured nerve roots, and the trigeminal nucleus in the brainstem (8). Any possible 
explanation underlying the pathophysiology of such a disease should account for both the abnormal 
generation of sensory impulses and their spreading through fibers that normally play different 
functional activities. It has been pointed out that the pathological substrate of this condition is 
mainly associated with the demyelination of the trigeminal root entry zone (9). In this regard, 
experimental evidence exists about ectopic impulses generation from demyelinated axons (10). 
Accordingly, the pulsatile compression would result in progressive demyelination and subsequent 
ephaptic coupling providing aberrant impulses generation and spreading. The ephaptic cross-talk 
between sensory fibers and those delegated to painful stimuli transport can account for TN 
following the tactile stimulation of the trigger points. The frequent involvement of the trigeminal 
nerve root entry zone in patients suffering from demyelinating diseases reflects the fact that fibers 
subserving light touch and those involved in the generation of pain are in closest proximity in this 
region. Therefore, when the demyelination occurs in this region the ephaptic cross-talk between the 
two pathways is most likely to happen (11). 
The rapid clinical and electrophysiological recovery that often follows the microvascular 
decompression has questioned the central role of demyelination in the development of TN. 
However, it can be argued that the clinical improvement and electrophysiological recovery reflect 
two different processes. First, the rapid relief of the clinical symptoms probably indicates the 
termination of the ectopic generation of impulses and their ephaptic spreading to the adjacent fibers 
(10). The resolution of the nerve compression would allow the separation of the demyelinated 
axons, thus preventing the ephaptic cross-talk. The second process to be considered is that the 
improvement of nerve conduction reflects the rapid functional recovery of the large-caliber, fast-
conducting fibers that are not demyelinated (12). This is most likely to occur during the conduction 
of high-frequency trains of impulses. The knowledge that the clinical improvement can be 
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dissociated from the conduction recovery in some patients following microvascular decompression 
supports the concept that these are two distinct processes involved in the same pathological 
condition. 
Despite the progress achieved in recent years, the pathogenesis of some phenomena related to TN 
remains unclear. These include the occurrence of pain in areas outside the field of innervation of the 
V nerve and even by lights or loud noises. These findings require the involvement of central 
pathways still under investigation. 
Another point under debate is the occurrence of a refractory period of seconds to minutes after an 
attack of TN, during which further attacks cannot be provoked. Experimental studies have shown 
the length of time for which the nerve fibers are refractory to further excitation (13). However, the 
duration of the refractory period in these experimental studies is much shorter than that in patients 
with TN. Accordingly, besides demyelination, other factors could delay the restoration of 
membrane potentials and excitability after an episode of TN. These include the impairment of the 
mitochondrial ATP production due to the inadequate blood perfusion of the compressed nerve root 
from the neurovascular compression (11). After a burst of discharges, nerve hypoperfusion would 
generate a delay in restoring the ionic gradient, reduction in extracellular fluid and increasing in 
resistance to the ionic current between closely juxtaposed demyelinated axons (11).  
Whether remyelination occurs following microvascular decompression and if it plays a role in the 
initial symptomatic recovery is unclear. Apparently, remyelination cannot explain the immediate 
relief from neuralgia although it has been reported in spontaneous remission. In the long term, 
however, it is possible that remyelination can help in ensuring a sustained symptomatic relief (13).  
Though several studies have been clarified some physiopathological mechanisms underlying TN, 
the molecular basis remain elusive.  
In this issue of MOLECULAR MEDICINE, Tanaka and collaborators present a detailed and 
interesting paper describing the biophysical changes caused by the substitution of methionine 136 
by valine (MET126Val) in sodium channel Nav1.6 in a case study of typical TN (14). The mutation 
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substitutes a highly conserved residue in transmembrane segment 1 of domain 1 (DI/S1) of the 
channel and produces increase in peak transient and resurgent currents of NAv1.6. It also reduces 
threshold for action potential in trigeminal ganglion (TRG) neurons and enhances the neuronal 
evoked response and the fraction of neurons that fire at a higher rate than those expressing wild-
type (WT) channels. As suggested by the authors, the role for voltage-gated sodium channels in TN 
is consistent with the favorable response to carbamazepine and several line of evidence associate 
the role of NAV1.6 in the pathophysiology of different forms of pain including TN. The findings of 
this study support the notion that Met136Val channels produce an increase in the resurgent current 
in TRG neurons thus providing the physiological basis for enhanced evoked firing of TRG neurons 
expressing these channels.  
Even if the data are preliminary and limited by the single case analyzed, the study highlights a 
possible molecular basis in TN thus extending our knowledge in the cranial nerve dysfunction by 
vascular compression. Although the study represents a basic premise for future investigations, 
important issues still need to be addressed. First, It would be interesting to understand what happens 
following the neurovascular decompression treatment and whether a relationship between such a 
mutation and the ephaptic transmission exists. Also, it would be addressed if the discovery of 
Nav1.6 mutation can be extended to all the cases of nerve dysfunction such as hemifacial spasm, 
vertigo, spasmodic torticollis, that we do know are associated with vascular compression.  
Overall, the conclusions, well supported by the reported data, provide novel information that 
warrants further conclusive investigations. 
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